CUSTICS SINGAPORE PTE. LTD. (hereafter referred to as “CUSTICS SINGAPORE“) has successfully completed clinical study on its ‘Hautuki‘ growth nutrient patch in collaboration with Bestian Hospital, demonstrating its effectiveness in promoting height growth and confirming its safety. The study was conducted in adherence to Good Clinical Practice (GCP) standards and the approval of the Institutional Review Board (IRB), ensuring its reliability.
From January to November 2024, the study evaluated the effectiveness and safety of Hautuki on 40 children aged 5 to 12 years. The 8-week study revealed that children in the test group using Hautuki experienced an average height increase of 1.77 cm, compared to an average increase of 1.37 cm in the control group, who did not use the patch. This indicates that the test group achieved approximately 30% more growth than the control group.
The clinical study also yielded positive results regarding safety. No adverse effects were reported during the research period, leading to the conclusion that Hautuki is safe for long-term use.
“We are delighted that Hautuki has been scientifically proven to promote height growth and ensure safety,” said Kang-il Lee, CEO of CUSTICS SINGAPORE. “This clinical study allows us to strengthen consumer trust in our product, and we remain committed to developing safe and effective solutions that exceed customer expectations.”
Based on these clinical findings, Hautuki is expected to gain further attention in the growth products market, offering a reliable choice for consumers. The company plans to continue investing in research and quality improvements to enhance its offerings.
Distributor: Amit Biswas
Distributor Company: Grow With Amit
Contact: [email protected]
Media Contact
Company Name: Grow With Amit
Contact Person: Amit Biswas
Email: Send Email
Country: Singapore
Website: https://www.fiverr.com/grow_withamit